AU6873596A - Allergen-xcd32 fusion proteins - Google Patents

Allergen-xcd32 fusion proteins

Info

Publication number
AU6873596A
AU6873596A AU68735/96A AU6873596A AU6873596A AU 6873596 A AU6873596 A AU 6873596A AU 68735/96 A AU68735/96 A AU 68735/96A AU 6873596 A AU6873596 A AU 6873596A AU 6873596 A AU6873596 A AU 6873596A
Authority
AU
Australia
Prior art keywords
xcd32
allergen
fusion proteins
fusion
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68735/96A
Other languages
English (en)
Inventor
Geert C. Mudde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU6873596A publication Critical patent/AU6873596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Insects & Arthropods (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU68735/96A 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins Abandoned AU6873596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9516760.7A GB9516760D0 (en) 1995-08-16 1995-08-16 Organic compounds
GB9516760 1995-08-16
PCT/EP1996/003616 WO1997007218A1 (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins

Publications (1)

Publication Number Publication Date
AU6873596A true AU6873596A (en) 1997-03-12

Family

ID=10779307

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68735/96A Abandoned AU6873596A (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins

Country Status (16)

Country Link
EP (1) EP0846178A1 (hu)
JP (1) JPH11513025A (hu)
KR (1) KR19990036440A (hu)
CN (1) CN1193353A (hu)
AU (1) AU6873596A (hu)
BR (1) BR9610239A (hu)
CA (1) CA2227795A1 (hu)
CZ (1) CZ43798A3 (hu)
GB (1) GB9516760D0 (hu)
HU (1) HUP9802349A3 (hu)
IL (1) IL122898A0 (hu)
NO (1) NO980566L (hu)
PL (1) PL324897A1 (hu)
SK (1) SK19398A3 (hu)
TR (1) TR199800214T1 (hu)
WO (1) WO1997007218A1 (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
AU750358B2 (en) 1997-12-02 2002-07-18 Medarex, Inc. Cells expressing anti-Fc receptor binding components
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US8029803B2 (en) 2002-06-20 2011-10-04 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8025873B2 (en) 2002-06-20 2011-09-27 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8007805B2 (en) 2003-08-08 2011-08-30 Paladin Labs, Inc. Chimeric antigens for breaking host tolerance to foreign antigens
BG65715B1 (bg) * 2003-09-04 2009-08-31 Чавдар ВАСИЛЕВ Средство за селективно подтискане на патологични днк - специфични в клетки
BG65954B1 (bg) * 2005-01-05 2010-07-30 Чавдар ВАСИЛЕВ Средство за селективно подтискане активността на патологични автореактивни в-клетки
EP1829895A1 (en) * 2006-03-03 2007-09-05 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
US9636415B2 (en) 2006-03-03 2017-05-02 S-Target Therapeutics Gmbh Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
EP2861240B1 (en) 2012-06-15 2020-09-09 Immunomic Therapeutics, Inc. Nucleic acids for treatment of allergies
ES2897793T3 (es) 2012-07-13 2022-03-02 S Target Therapeutics Gmbh Vacuna inmunorreguladora
WO2014067993A1 (en) * 2012-11-01 2014-05-08 Veterinærinstituttet New fusion proteins for the treatment of allergic diseases
US9005630B2 (en) 2012-11-01 2015-04-14 Veterinaerinstituttet Fusion proteins for the treatment of allergic diseases
JP6395816B2 (ja) 2013-05-21 2018-09-26 ティーワイジー・オンコロジー・リミテッド ガストリンペプチド免疫原組成物
CN113186167B (zh) * 2021-04-28 2021-11-30 中国食品药品检定研究院 用于测定抗cd20单克隆抗体药物adcp生物学活性的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024281A1 (en) * 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
AU2670995A (en) * 1994-05-26 1995-12-21 Innogenetics N.V. New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness

Also Published As

Publication number Publication date
MX9801253A (es) 1998-05-31
JPH11513025A (ja) 1999-11-09
SK19398A3 (en) 1998-09-09
WO1997007218A1 (en) 1997-02-27
BR9610239A (pt) 1999-06-15
HUP9802349A2 (hu) 1999-01-28
IL122898A0 (en) 1998-08-16
EP0846178A1 (en) 1998-06-10
GB9516760D0 (en) 1995-10-18
NO980566D0 (no) 1998-02-10
CZ43798A3 (cs) 1998-06-17
TR199800214T1 (xx) 1998-06-22
CN1193353A (zh) 1998-09-16
HUP9802349A3 (en) 1999-04-28
PL324897A1 (en) 1998-06-22
NO980566L (no) 1998-02-10
CA2227795A1 (en) 1997-02-27
KR19990036440A (ko) 1999-05-25

Similar Documents

Publication Publication Date Title
AU3827695A (en) Antigen-binding fusion proteins
AU4382193A (en) BPI-immunoglobulin fusion proteins
AU9482098A (en) Fusion protein systems
AU6255096A (en) Pegylated modified proteins
AU4766196A (en) Anti-obesity proteins
AU4774496A (en) Anti-obesity proteins
AU4862096A (en) Anti-obesity proteins
AU4705196A (en) Anti-obesity proteins
AU4774696A (en) Anti-obesity proteins
AU4766096A (en) Anti-obesity proteins
AU2288595A (en) Ubiquitin-based split protein sensor
AU4922497A (en) Interleukin-18-receptor proteins
AU5065198A (en) Fusion proteins having increased half-lives
AU3562299A (en) Inhibin-hbc fusion protein
AU1115897A (en) Nima interacting proteins
AU5181296A (en) Anti-obesity proteins
AU4413096A (en) Phenylalanine free proteins
AU6873596A (en) Allergen-xcd32 fusion proteins
AU6489996A (en) Methods for increasing protein expression
AU7294396A (en) Protein detection
AU4394396A (en) Modified peptides
AU9798398A (en) Gfp-annexin fusion proteins
GB9510830D0 (en) Proteins
AU7684896A (en) Fas ligand fusion protein
AU5635896A (en) Recombinant endotoxin-neutralizing proteins

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted